p53 abnormalities in B-cell prolymphocytic leukemia

Blood

Volumn 89, Issue 6, 1997, Pages 2015-2023

  Lens, Daniela ^b   De Schouwer, Pierre J J C ^b   Hamoudi, Rifat A ^b   Abdul Rauf, Munah ^b   Farahat, Nahla ^b   Matutes, Estella ^b   Crook, Tim ^b   Dyer, Martin J S ^b   Catovsky, Daniel ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; DNA SEQUENCE; FEMALE; GENE DELETION; GENE INSERTION; GENE MUTATION; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROLYMPHOCYTIC LEUKEMIA; PROTEIN EXPRESSION; SINGLE STRAND CONFORMATION POLYMORPHISM;

EID: 0030951813     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.6.2015     Document Type: Article

References (42)

1. Galton DAG, Goldman JM, Wiltshaw E, Catovsky D, Henry K, Goldenberg GJ: Prolymphocytic leukaemia. Br J Haematol 27:7, 1974
2. Catovsky D, Galetto J, Okos A, Galton DAG, Wiltshaw E, Stathopoulos G: Prolymphocytic leukemia of B and T cell type. Lancet 2:232, 1973
3. Melo JV, Wardle J, Chetty M, England J, Lewis SM, Galton DA, Catovsky D: The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia. III. Evaluation of cell size by morphology and volume measurements. Br J Haematol 64:469, 1986
4. Brito-Babapulle V, Pittman S, Melo JV, Pomfret M, Catovsky D: Cytogenetic studies on prolymphocytic leukemia. I. B-cell prolymphocytic leukemia. Hematol Pathol 1:27, 1987
5. Kay NE, Suen R, Ranheim E, Peterson LC: Confirmation of Rb gene defects in B-CLL clones and evidence for variable predominance of the Rb defective cells within the CLL clone. Br J Haematol 84:257, 1993
6. Volgenstein B, Kinzler KW: p53 function and dysfunction. Cell 70:523, 1992
7. Momand J, Zambetti GP, Olson DC, George D, Levine AJ: The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69:1237, 1992
8. El-Deiry W, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Volgenstein B: Wafl, a potential mediator of p53 tumor suppression. Cell 75:817, 1993
9. Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, Liebermann DA, Hoffman B, Reed JC: Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9:1799, 1994
10. Miyashita T, Reed JC: Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80:293, 1995
11. Nigro JM, Baker SJ, Preisinger AC, Jessup JM, Hostetter R, Cleary K, Bigner SH, Davidson N, Baylin S, Devilee P, Glover T, Collins FS, Weston A, Modali R, Harris CC, Volgenstein B: Mutations in the p53 gene occur in diverse human tumour types. Nature 342:705, 1989
12. Levine AJ, Momand J, Finlay CA: The p53 tumour suppressor gene. Nature 351:453, 1991
13. Imamura N, Kuramoto A, Ishihara H, Shimizu S: Detection of high-incidence of h-ras oncogene point mutations in acute myelogenous leukemia. Am J Hematol 211:151, 1993
14. Newcomb EW: p53 gene-mutations in lymphoid diseases and their possible relevance to drug-resistance. Leuk Lymphoma 17:211, 1995
15. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Gallon DA, Gralnick HR, Sultan C, French-American-British (FAB) Cooperative Group: Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. French-American-British (FAB) Cooperative Group. J Clin Pathol 42:567, 1989
16. Mason D, Cordell J, Abdulaziz A, Naiem M, Bordenave G: Preparation of peroxidase anti-peroxidase (PAP) complexes for immunohistological labelling of monoclonal antibodies. J Histochem Cytochem 11:1114, 1982
17. Harlow E, Crawford LV, Pim DC, Williamson NM: Monoclonal antibodies specific for simian virus 40 tumour antigen. J Virol 39:861, 1981
18. Dyer MJS, Heward JM, Zani VJ, Buccheri V, Catovsky D: Unusual deletions within the immunoglobulin heavy-chain locus in acute leukemias. Blood 82:865, 1993
19. Kondoleon S, Vissing H, Luo XY, Magenis RE, Kellogg J, Litt M: A hypervariable RFLP on chromosome 17p13 is defined by an arbitrary single copy probe p144-D6 [HGM9 No. D17S34]. Nucleic Acids Res 15:10605, 1987
20. Nakamura Y, Ballard L, Leppert M, O'Connell PO, Lathrop GM, Lalouel J-M, White R: Isolation and mapping of a polymorphic DNA sequence (pYNZ22) on chromosome 17p [D17S30], Nucleic Acids Res 16:5707, 1988
21. Cheng J, Haas M: Frequent mutations in the p53 tumor suppressor gene in human leukemia T-cell lines. Mol Cel Biol 10:5502, 1990
22. Caron de Fromentel C, Soussi T: TP53 Tumor suppressor gene: A model for investigating human mutagenesis. Genes Chromosom Cancer 4:1, 1992
23. Farrell PJ, Gordon JA, Shanahan F, Vousden KH, Crook T: p53 is frequently mutated in Burkitt's lymphoma cell lines. EMBO J 10:2879, 1991
24. Adamson DJA, Thompson WD, Dawson AA, Bennett B, Haites NE: p53 mutation and expression in lymphoma. Br J Cancer 72:150, 1995
25. Baldini L, Fracchiolla NS, Cro LM, Trecca D, Romitti L, Polli E, Maiolo AT, Neri A: Frequent p53 gene involvement in splenic-cell leukemia/lymphomas of possible marginal zone origin. Blood 84:270, 1994
26. Louie DC, Offit K, Jaslow R, Parsa NZ, Murty VVVS, Schluger A, Chaganti RSK: p53 overexpression as a marker of poor prognosis in mantle cell lymphoma with t(11;14) (q13;q32). Blood 86:2892, 1995
27. Gaidano G, Ballerini P, Gong JZ, Inghirami G, Neri A, Newcomb EW, Magrath IT, Knowles DM, Dalla-Favera R: p53 mutations in human lymphoid malignancies: Association with Burkitt lymphoma and chronic lymphocytic-leukemia. Proc Natl Acad Sci USA 88:5413, 1991
28. Fenaux P, Preudhomme C, Lai JL, Quiquandon I, Jonveaux P, Vanrumbeke M, Sartiaux C, Morel P, Loucheux-Lefebvre MH, Bauters F, Berger R, Kerckaert JP: Mutations of the p53 gene in B-cell chronic lymphocytic leukemia: A report on 39 cases with cytogenetic analysis. Leukemia 6:246, 1992
29. El Rouby S, Thomas A, Costin D, Rosenberg CR, Potmesil M, Silber R, Newcomb EW: p53 gene mutation in B-cell chronic lymphocytic leukemia is associated with drug-resistance and is independent of mdrl/mdr3 gene expression. Blood 82:3452, 1993
30. Gaidano G, Newcomb EW, Gong JZ, Tassi V, Neri A, Cortelezzi A, Calori R, Baldini L, Dalla-Favera R: Analysis of alterations of oncogenes and tumor-suppressor genes in chronic lymphocyticleukemia. Am J Pathol 144:1312, 1994
31. Corradini P, Inghirami G, Astolfi M, Ladetto M, Voena C, Ballerini P, Gu W, Nilsson K, Knowles DM, Boccadoro M, Pileri A, Dalla-Favera R: Inactivation of tumor suppressor genes, p53 and rb1 in plasma cell dyscrasias. Leukemia 8:758, 1994
32. Lo Coco F, Gaidano G, Louie DC, Offit K, Chaganti RSK, Dalla-Favera R: P53 mutations are associated with histologic transformation of follicular lymphoma. Blood 82:2289, 1993
33. Aguilar-Santelises M, Magnusson KP, Wiman KG, Mellstedt H, Jondal M: Progressive B-cell chronic lymphocytic leukemia frequently exhibits aberrant p53 expression. Int J Cancer 58:474, 1994
34. Hollstein M, Sidransky D, Vogelstein B, Harris CC: p53 mutations in human cancers. Science 253:49, 1991
35. Greenblatt MS, Bennett WP, Hollstein M, Harris CC: Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis. Cancer Res 54:4855, 1994
36. Hollstein M, Rice K, Greenblatt MS, Soussi T, Fuchs R, Sorlie T, Hovig E, Smith-Sorensen B, Montesano R, Harris CC: Database of p53 gene somatic mutations in human tumors and cell lines. Nucleic Acids Res 22:3551, 1994
37. Soussi T, Legros Y, Lubin R, Ory K, Schlichtholz B: Multifactorial analysis of p53 alteration in human cancer: A review. Int J Cancer 57:1, 1994
38. Baker SJ, Preisinger AC, Jessup JM, Paraskeva C, Markowitz S. Wilson JKV, Hamilton S, Vogelstein B: P53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res 50:7717, 1990
39. Thompson AM, Anderson TJ, Condie A, Prosser J, Chetty U, Carter DC, Evans HJ, Steel CM: p53 allele losses, mutations and expression in breast cancer and their relationship to clinicopathological parameters. Int J Cancer 50:528, 1992
40. Harris CC, Hollstein M: Clinical implications of the p53 tumor suppressor gene. N Engl J Med 329:1318, 1993
41. Melo JV, Catovsky D, Gregory WM, Galton DA: The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia. IV. Analysis of survival and prognostic features. Br J Haematol 65:23, 1987
42. Binet JL, Auquier A, Dighiero G, Chastang C, Piguet H, Goasguen J, Vaugier G, Potron G, Colona P, Oberling F, Thomas M, Tchernia G, Jacquillat C, Boivin P, Lesty C, Duault MT, Monconduit M, Belabbes S, Gremy F: A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 48:198, 1981